Animals that dwell at high altitudes have adapted to cope with low oxygen levels, a condition that damages a vital part of ...

Saturday marked just the third time in regular-season history—and fifth time ever, including the NCAA tournament—that the Nos. 1, 2, 3 and 4 teams play each other on the same day. Seriously, it’s that ...

New research defines distinct therapeutic strategies for the 2 classes of CALR mutations in myelofibrosis, with implications for future patient management and clinical trial design. The central ...

Scientists at Mount Sinai have created an artificial intelligence system that can predict how likely rare genetic mutations are to actually cause disease. By combining machine learning with millions ...

INCA033989 targets mutCALR in ET patients with Type 1 CALR mutations, showing promise in early trials with rapid, durable hematological responses and a favorable safety profile. CALR mutations are ...

President Donald Trump on Wednesday officially launched his “gold card” visa, a new immigration pathway that will allow foreigners to pay $1 million to expedite their visa application, or have ...

The wellness space has grown fast. The supplement market is crowded, and products vary widely in formulation and quality. People have noticed. Now, they’re asking for real results—outcomes, not just ...

Add Yahoo as a preferred source to see more of our stories on Google. “The End,” Five Finger Death Punch’s latest radio single, featuring Japanese rockers BABYMETAL, ascends 2-1 to become the former’s ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved ziftomenib for adult patients with relapsed or refractory acute myeloid leukemia with a ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Compass Pathways, which ...

MPN-BP transformation is driven by sequential mutations disrupting genomic stability, with TP53 mutations being strong predictors of progression. TP53 mutations confer a selective growth advantage, ...